Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00134914 · ClinicalTrials.gov registry record · NA
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00134914 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 10 participants.
The verdict
NCT00134914, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Buprenorphine is a treatment for opioid dependence. Naloxone is given in addition to buprenorphine in order to limit the abuse potential that is commonly associated with buprenorphine. The purpose of this study is to examine the effects of buprenorphine/naloxone when given through different routes and at different doses.
Interventions
- DRUG Buprenorphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 1996-08 |
| Est. Completion | 1998-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00134914
The ClinicalTrials.gov registry entry for NCT00134914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00134914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00134914 about?
NCT00134914 is a clinical study titled "Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence". Buprenorphine is a treatment for opioid dependence. Naloxone is given in addition to buprenorphine in order to limit the abuse potential that is commonly associated with buprenorphine. The purpose of this study is to examine the effects of buprenorphine/naloxone when given through different routes a...
What is the current status of trial NCT00134914?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 1996-08. Estimated completion is 1998-05.
What interventions are being tested in trial NCT00134914?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00134914?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.